MyAverix Finance
NS · Pharmaceuticals
Orchid Pharma Ltd (ORCHPHARMA)
Pharmaceuticals & Biotechnology
Orchid Pharma Ltd (ORCHPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $50.72B, P/E ratio is 112.23, net margin is 9.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ORCHPHARMA
Orchid Pharma Ltd (ORCHPHARMA) — FAQ
What is Orchid Pharma Ltd's market cap?
Orchid Pharma Ltd (ORCHPHARMA) has a reported market cap of $50.72B (data as of 2026-07-10).
What is ORCHPHARMA's P/E ratio?
The price-to-earnings (P/E) ratio for Orchid Pharma Ltd (ORCHPHARMA) is 112.23 (data as of 2026-07-10).
Does Orchid Pharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Orchid Pharma Ltd (ORCHPHARMA). Check the MyAverix Finance app for the latest dividend data.
What sector is Orchid Pharma Ltd in?
Orchid Pharma Ltd (ORCHPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ORCHPHARMA listed on?
ORCHPHARMA is listed on NS.
What is Orchid Pharma Ltd's net margin?
Orchid Pharma Ltd (ORCHPHARMA) reports a net margin of 9.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.